Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre van Damme

Showing results (211-220 of 365) with videos related to

Pageof 37
Sort By:
Scandinavian Journal of Infectious Diseases|August 16, 2005
Prevention of viral hepatitis in the Nordic countries and GermanyDavid Fitzsimons, Guido François, Katharina Alpers, et al.
Infection|July 17, 2024
Innovative approaches for vaccine trials as a key component of pandemic preparedness - a white paperUllrich Bethe, Zoi D Pana, Christian Drosten, et al.
The Pediatric Infectious Disease Journal|June 20, 2015
A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil® in 9-15-Year-Old GirlsTimo Vesikari, Nicholas Brodszki, Pierre van Damme, et al.
Frontiers in Public Health|May 1, 2023
Planning, implementation, and sustaining high coverage of human papillomavirus (HPV) vaccination programs: What works in the context of low-resource countries?Dur-E-Nayab Waheed, Ana Bolio, Dominique Guillaume, et al.
BMC Infectious Diseases|December 22, 2010
Five years follow-up following two or three doses of a hepatitis B vaccine in adolescents aged 11-15 years: a randomised controlled studyPierre Van Damme, Anna Moiseeva, Igor Marichev, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 9, 2021
Immunogenicity and safety of HBAI20 Hepatitis B vaccine in non-responders: Double-blinded, randomised, controlled phase 2 trialÖzgür M Koc, Philippe de Smedt, Cécile Kremer, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 13, 2020
How nasopharyngeal pneumococcal carriage evolved during and after a PCV13-to-PCV10 vaccination programme switch in Belgium, 2016 to 2018Ine Wouters, Stefanie Desmet, Liesbet Van Heirstraeten, et al.
Human Vaccines & Immunotherapeutics|February 11, 2015
Prevalence of rotavirus antibodies in breast milk and inhibitory effects to rotavirus vaccinesNguyen V Trang, Tessa Braeckman, Tinne Lernout, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 9, 2012
Anal human papillomavirus DNA in women at a colposcopy clinicKathleen W M D'Hauwers, Tine Cornelissen, Christophe E Depuydt, et al.
The Journal of Infection|September 15, 2014
Herpes zoster is associated with herpes simplex and other infections in under 60 year-oldsBenson Ogunjimi, Frank Buntinx, Stephaan Bartholomeeusen, et al.
Pageof 37

Showing results (211-220 of 365) with videos related to

Sort By:
Pageof 37
Scandinavian Journal of Infectious Diseases|August 16, 2005
Prevention of viral hepatitis in the Nordic countries and GermanyDavid Fitzsimons, Guido François, Katharina Alpers, et al.
Infection|July 17, 2024
Innovative approaches for vaccine trials as a key component of pandemic preparedness - a white paperUllrich Bethe, Zoi D Pana, Christian Drosten, et al.
The Pediatric Infectious Disease Journal|June 20, 2015
A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil® in 9-15-Year-Old GirlsTimo Vesikari, Nicholas Brodszki, Pierre van Damme, et al.
Frontiers in Public Health|May 1, 2023
Planning, implementation, and sustaining high coverage of human papillomavirus (HPV) vaccination programs: What works in the context of low-resource countries?Dur-E-Nayab Waheed, Ana Bolio, Dominique Guillaume, et al.
BMC Infectious Diseases|December 22, 2010
Five years follow-up following two or three doses of a hepatitis B vaccine in adolescents aged 11-15 years: a randomised controlled studyPierre Van Damme, Anna Moiseeva, Igor Marichev, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 9, 2021
Immunogenicity and safety of HBAI20 Hepatitis B vaccine in non-responders: Double-blinded, randomised, controlled phase 2 trialÖzgür M Koc, Philippe de Smedt, Cécile Kremer, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 13, 2020
How nasopharyngeal pneumococcal carriage evolved during and after a PCV13-to-PCV10 vaccination programme switch in Belgium, 2016 to 2018Ine Wouters, Stefanie Desmet, Liesbet Van Heirstraeten, et al.
Human Vaccines & Immunotherapeutics|February 11, 2015
Prevalence of rotavirus antibodies in breast milk and inhibitory effects to rotavirus vaccinesNguyen V Trang, Tessa Braeckman, Tinne Lernout, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 9, 2012
Anal human papillomavirus DNA in women at a colposcopy clinicKathleen W M D'Hauwers, Tine Cornelissen, Christophe E Depuydt, et al.
The Journal of Infection|September 15, 2014
Herpes zoster is associated with herpes simplex and other infections in under 60 year-oldsBenson Ogunjimi, Frank Buntinx, Stephaan Bartholomeeusen, et al.
Pageof 37